NorthRock Partners’s Hologic HOLX Stock Holding History

NorthRock Partners’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,366	Closed	-$295K	–	755
2025 Q3	$295K	Buy	+4,366	New	+$290K	0.01%	705

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

NorthRock Partners's HOLX Position: Q4 2025 in Review

NorthRock Partners sold out of Hologic (HOLX) in Q4 2025, closing a stake of 4,366 shares — an estimated $295K sold.

NorthRock Partners first reported a position in HOLX in Q3 2025 and held it in 1 quarter. The position peaked at $295K in Q3 2025. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

NorthRock Partners reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
NorthRock Partners sold 4,366 Hologic shares in Q4 2025, an estimated $295K.
NorthRock Partners first reported a position in Hologic in Q3 2025 and held it in 1 quarter.
NorthRock Partners's Hologic position peaked at $295K in Q3 2025.
749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on NorthRock Partners's 13F filing for Q4 2025, filed 17 Feb 2026.